Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CBT vs TROX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.24B
5Y Perf.+127.5%
TROX
Tronox Holdings plc

Chemicals

Basic MaterialsNYSE • US
Market Cap$1.34B
5Y Perf.+26.7%

CBT vs TROX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CBT logoCBT
TROX logoTROX
IndustryChemicals - SpecialtyChemicals
Market Cap$4.24B$1.34B
Revenue (TTM)$3.58B$2.92B
Net Income (TTM)$285M$-359M
Gross Margin24.8%5.8%
Operating Margin15.7%-4.8%
Forward P/E13.0x
Total Debt$1.22B$3.59B
Cash & Equiv.$258M$211M

CBT vs TROXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CBT
TROX
StockMay 20May 26Return
Cabot Corporation (CBT)100227.5+127.5%
Tronox Holdings plc (TROX)100126.7+26.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: CBT vs TROX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBT leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Tronox Holdings plc is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
CBT
Cabot Corporation
The Income Pick

CBT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 4 yrs, beta 0.78, yield 2.2%
  • Rev growth -7.0%, EPS growth -10.4%, 3Y rev CAGR -4.9%
  • Lower volatility, beta 0.78, Low D/E 71.3%, current ratio 1.61x
Best for: income & stability and growth exposure
TROX
Tronox Holdings plc
The Long-Run Compounder

TROX is the clearest fit if your priority is long-term compounding and defensive.

  • 116.1% 10Y total return vs CBT's 115.7%
  • Beta 2.37, yield 3.6%, current ratio 2.46x
  • -5.7% revenue growth vs CBT's -7.0%
Best for: long-term compounding and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthTROX logoTROX-5.7% revenue growth vs CBT's -7.0%
Quality / MarginsCBT logoCBT8.0% margin vs TROX's -12.3%
Stability / SafetyCBT logoCBTBeta 0.78 vs TROX's 2.37, lower leverage
DividendsCBT logoCBT2.2% yield, 4-year raise streak, vs TROX's 3.6%
Momentum (1Y)TROX logoTROX+76.9% vs CBT's +13.8%
Efficiency (ROA)CBT logoCBT7.4% ROA vs TROX's -7.7%, ROIC 17.4% vs -0.3%

CBT vs TROX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B
TROXTronox Holdings plc
FY 2025
TiO2
79.3%$2.3B
Product and Service, Other
11.2%$326M
Zircon
9.5%$274M

CBT vs TROX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBTLAGGINGTROX

Income & Cash Flow (Last 12 Months)

CBT leads this category, winning 4 of 6 comparable metrics.

CBT and TROX operate at a comparable scale, with $3.6B and $2.9B in trailing revenue. CBT is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to TROX's -12.3%. On growth, TROX holds the edge at +3.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCBT logoCBTCabot CorporationTROX logoTROXTronox Holdings p…
RevenueTrailing 12 months$3.6B$2.9B
EBITDAEarnings before interest/tax$731M$166M
Net IncomeAfter-tax profit$285M-$359M
Free Cash FlowCash after capex$459M-$139M
Gross MarginGross profit ÷ Revenue+24.8%+5.8%
Operating MarginEBIT ÷ Revenue+15.7%-4.8%
Net MarginNet income ÷ Revenue+8.0%-12.3%
FCF MarginFCF ÷ Revenue+12.8%-4.8%
Rev. Growth (YoY)Latest quarter vs prior year-3.4%+3.0%
EPS Growth (YoY)Latest quarter vs prior year-23.1%+7.1%
CBT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

TROX leads this category, winning 3 of 4 comparable metrics.

On an enterprise value basis, CBT's 6.7x EV/EBITDA is more attractive than TROX's 16.8x.

MetricCBT logoCBTCabot CorporationTROX logoTROXTronox Holdings p…
Market CapShares × price$4.2B$1.3B
Enterprise ValueMkt cap + debt − cash$5.2B$4.7B
Trailing P/EPrice ÷ TTM EPS13.50x-2.83x
Forward P/EPrice ÷ next-FY EPS est.13.04x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple6.71x16.80x
Price / SalesMarket cap ÷ Revenue1.14x0.46x
Price / BookPrice ÷ Book value/share2.58x0.92x
Price / FCFMarket cap ÷ FCF10.86x
TROX leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

CBT leads this category, winning 9 of 9 comparable metrics.

CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-30 for TROX. CBT carries lower financial leverage with a 0.71x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), CBT scores 6/9 vs TROX's 2/9, reflecting solid financial health.

MetricCBT logoCBTCabot CorporationTROX logoTROXTronox Holdings p…
ROE (TTM)Return on equity+16.8%-30.4%
ROA (TTM)Return on assets+7.4%-7.7%
ROICReturn on invested capital+17.4%-0.3%
ROCEReturn on capital employed+21.3%-0.4%
Piotroski ScoreFundamental quality 0–962
Debt / EquityFinancial leverage0.71x2.48x
Net DebtTotal debt minus cash$957M$3.4B
Cash & Equiv.Liquid assets$258M$211M
Total DebtShort + long-term debt$1.2B$3.6B
Interest CoverageEBIT ÷ Interest expense14.72x-1.16x
CBT leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CBT and TROX each lead in 3 of 6 comparable metrics.

A $10,000 investment in CBT five years ago would be worth $14,321 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, TROX leads with a +76.9% total return vs CBT's +13.8%. The 3-year compound annual growth rate (CAGR) favors CBT at 7.0% vs TROX's -8.6% — a key indicator of consistent wealth creation.

MetricCBT logoCBTCabot CorporationTROX logoTROXTronox Holdings p…
YTD ReturnYear-to-date+21.9%+98.1%
1-Year ReturnPast 12 months+13.8%+76.9%
3-Year ReturnCumulative with dividends+22.5%-23.6%
5-Year ReturnCumulative with dividends+43.2%-55.1%
10-Year ReturnCumulative with dividends+115.7%+116.1%
CAGR (3Y)Annualised 3-year return+7.0%-8.6%
Evenly matched — CBT and TROX each lead in 3 of 6 comparable metrics.

Risk & Volatility

CBT leads this category, winning 2 of 2 comparable metrics.

CBT is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs TROX's 79.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCBT logoCBTCabot CorporationTROX logoTROXTronox Holdings p…
Beta (5Y)Sensitivity to S&P 5000.78x2.37x
52-Week HighHighest price in past year$84.60$10.59
52-Week LowLowest price in past year$58.33$2.86
% of 52W HighCurrent price vs 52-week peak+96.1%+79.4%
RSI (14)Momentum oscillator 0–10071.758.5
Avg Volume (50D)Average daily shares traded374K3.1M
CBT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CBT and TROX each lead in 1 of 2 comparable metrics.

Wall Street rates CBT as "Buy" and TROX as "Buy". Consensus price targets imply -4.0% upside for CBT (target: $78) vs -13.8% for TROX (target: $7). For income investors, TROX offers the higher dividend yield at 3.60% vs CBT's 2.18%.

MetricCBT logoCBTCabot CorporationTROX logoTROXTronox Holdings p…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$78.00$7.25
# AnalystsCovering analysts1517
Dividend YieldAnnual dividend ÷ price+2.2%+3.6%
Dividend StreakConsecutive years of raises40
Dividend / ShareAnnual DPS$1.77$0.30
Buyback YieldShare repurchases ÷ mkt cap+4.0%0.0%
Evenly matched — CBT and TROX each lead in 1 of 2 comparable metrics.
Key Takeaway

CBT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TROX leads in 1 (Valuation Metrics). 2 tied.

Best OverallCabot Corporation (CBT)Leads 3 of 6 categories
Loading custom metrics...

CBT vs TROX: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is CBT or TROX a better buy right now?

For growth investors, Tronox Holdings plc (TROX) is the stronger pick with -5.

7% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CBT or TROX?

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.

2%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: TROX returned +116. 1% versus CBT's +115. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CBT or TROX?

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

78β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 202% more volatile than CBT relative to the S&P 500. On balance sheet safety, Cabot Corporation (CBT) carries a lower debt/equity ratio of 71% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.

04

Which is growing faster — CBT or TROX?

By revenue growth (latest reported year), Tronox Holdings plc (TROX) is pulling ahead at -5.

7% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Cabot Corporation grew EPS -10. 4% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, CBT leads at -4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — CBT or TROX?

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus -0. 7% for TROX. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is CBT or TROX more undervalued right now?

Analyst consensus price targets imply the most upside for CBT: -4.

0% to $78. 00.

07

Which pays a better dividend — CBT or TROX?

All stocks in this comparison pay dividends.

Tronox Holdings plc (TROX) offers the highest yield at 3. 6%, versus 2. 2% for Cabot Corporation (CBT).

08

Is CBT or TROX better for a retirement portfolio?

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78), 2. 2% yield, +115. 7% 10Y return). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBT: +115. 7%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between CBT and TROX?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CBT is a small-cap deep-value stock; TROX is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CBT

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

TROX

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Dividend Yield > 1.4%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CBT and TROX on the metrics below

Revenue Growth>
%
(CBT: -3.4% · TROX: 3.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.